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Edited by Felix WielandAbstract Cyclophilin 40 (CyP40), an immunophilin cochaper-
one present in steroid receptor-Hsp90 complexes, contains an
N-terminal peptidylprolyl isomerase (PPIase) domain separated
from a C-terminal Hsp90-binding tetratricopeptide repeat
(TPR) domain by a 30-residue linker. To map CyP40 chaperone
function, CyP40 deletion mutants were prepared and analysed
for chaperone activity. CyP40 fragments containing the PPIase
domain plus linker or the linker region and the adjoining TPR
domain retained chaperone activity, whilst individually, the cat-
alytic and TPR domains were devoid of chaperoning ability.
CyP40 chaperone function then, is localized within the linker
that forms a binding cleft with potential to accommodate non-na-
tive substrates.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cyclophilin 40 (CyP40), a 40 kDa cyclosporin A-binding
immunophilin, was initially isolated as a component of estro-
gen aporeceptor complexes in association with heat shock
protein 90 (Hsp90) [1,2]. CyP40 bears sequence and structural
homology with other members of the large immunophilin
protein family, such as FKBP51 and FKBP52, which bind
the immunosuppresant FK506 [3]. These immunophilins are
characterised by a binding site for the immunosuppressive
drug located in the N-terminal domain, overlapping a pepti-
dylprolyl isomerase (PPIase) function. They also possess a
domain of three tetratricopeptide repeat (TPR) units at theirAbbreviations: CyP40, cyclophilin 40; bCyP40, bovine cyclophilin 40;
FKBPn, FK506 binding protein of n kDa; GR, glucocorticoid recep-
tor; Hspn, heat shock protein of n kDa; GST, glutathione S-transfer-
ase; PPIase, peptidylprolyl isomerase; TPR, tetratricopeptide repeat
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doi:10.1016/j.febslet.2006.04.039C-terminal ends which directs speciﬁc protein–protein inter-
actions [4,5].
These TPR-containing immunophilins are present in mature
steroid receptor heterocomplexes formed in a step-wise, dy-
namic assembly process involving the Hsp70 and Hsp90
molecular chaperones and assisted by several cochaperone
partners [6]. Hsp90, an abundant molecular chaperone whose
association with steroid receptors is critical for hormone bind-
ing and signal transduction [6], exists within mature unacti-
vated receptor heterocomplexes as a homodimer.
Immunophilins interact directly with Hsp90 through their
TPR domain and compete for a common binding site posi-
tioned in the C-terminal region of the molecular chaperone
[7,8].
Studies of cortisol insensitivity in New World primates re-
vealed lowered hormone binding aﬃnity of the glucocorticoid
receptor (GR), attributed to high expression levels of
FKBP51 [9]. In a yeast model, FKBP52 selectively potenti-
ated GR transcriptional activity which could be blocked by
co-expression of FKBP51 [10]. The immunophilins may
therefore have a role in regulating hormone recognition and
this is thought to be directed by FKBP52 PPIase activity,
which targets speciﬁc proline residue(s) in the ligand-binding
domain of the receptor [5,10].
In addition to PPIase function and Hsp90 binding, chaper-
one activity has been reported for CyP40 [11,12], FKBP51
[12] and FKBP52 [11,13], as well as for p23, a partner cochap-
erone present in mature steroid receptor heterocomplexes
[6,14,15]. Speciﬁc inhibition of PPIase activity by its cognate
immunosuppressant excluded a role for immunophilin cata-
lytic activity in chaperone function [11,13]. Of the two yeast
CyP40 homologues, Cpr6 has greater PPIase activity over
Cpr7, although Cpr7 is a more potent molecular chaperone
[16]. Deletion of Cpr7 resulted in reduced GR-regulated activ-
ity [17]. Additional studies suggested that the inﬂuence of Cpr7
on GR activity does not involve the PPIase domain, but rather
the TPR-containing carboxyl terminus [18].
To gain further insights into the role played by CyP40 in ste-
roid receptor heterocomplexes, we mapped the domain for
CyP40 chaperone function. We provide evidence that the chap-
erone function of CyP40 resides within a hydrophobic cleft be-
tween the PPIase and TPR domains and maps speciﬁcally to
the linker region separating these two domains.blished by Elsevier B.V. All rights reserved.
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2.1. Expression constructs and puriﬁcation of GST- and His-CyP40
related proteins
Expression plasmids for glutathione S-transferase (GST)-bovine
CyP40 (bCyP40) full-length and the deletions 185–370, 1–213 and
1–352 (Fig. 1) have been described previously [19]. For GST-bCyP40
1–185 and 216–370 constructs, DNA encoding these fragments was
ampliﬁed by PCR from a pGEX2T-bCyP40 full-length template
and cloned into the pGEX4T.1 and pGEX2T vectors (Amersham
Biosciences), respectively. Similarly, the His-bCyP40 1–184, 1–215
and 1–235 constructs were prepared by PCR ampliﬁcation using
the pGEX2T-bCyP40 full-length template and cloned into the
pET28a(+) vector (Novagen). Generation of GST-bCyP40 185–
370D243–256 was accomplished by PCR using pGEM-3Z-bCyP40
1–370 as a template [19] and oligonucleotide primers incorporating
BalI (5 0 end) and SmaI (3 0 end) restriction sites. A BalI site existing
at amino acid position 242 in bCyP40 was designed into the forward
primer immediately preceding the nucleotide sequence for amino acid
positions 257–264. The PCR product was subjected to BalI and SmaI
digestion and ligated into pGEX2T-bCyP40 185-370 previously di-
gested with BalI and SmaI. The pET28a(+)-hHsp90b 527–724 plas-
mid for His-hHsp90b 527–724 protein expression has been
previously described [20].Fig. 1. Schematic of GST-bCyP40 wild-type (WT) fusion protein and deletio
dark boxes represent units of the TPR domain. The solid bar indicates the li
shown in the last construct represents deleted amino acids. The GST moietyPlasmids for bacterial expression of GST and GST- and His-CyP40
fusion proteins were transformed into E. coli BL21 (codon +) cells and
were puriﬁed according to previously described methods [20]. Recov-
ered protein eluates were pooled, then concentrated and equilibrated
with chaperone assay buﬀer (50 mM HEPES, pH 7.0, 100 mM NaCl)
in a Centricon YM-30 (Millipore, Bedford, MA) before storage at
70 C. GST-bCyP40 216–370 gave a low recovery and was therefore
dialysed against chaperone assay buﬀer using Slide-A-Lyzer dialysis
cassettes (Perbio Science, Cheshire, UK). Protein concentration was
determined by the Bradford assay [21].
2.2. Pull-down assays
All constructs generated previously had been assessed for binding to
Hsp90 [19]. The GST-bCyP40 216–370 and 185–370D243–256 con-
structs (0.4 lM) were incubated with puriﬁed His-hHsp90b 527–724
(1.8 lM) and subjected to a pull-down assay as described previously
[22]. After SDS–PAGE, resolved proteins were visualized by Coomas-
sie staining and Hsp90 binding status was further evaluated by
Western blot analysis with AC88 antibody [23] to detect Hsp90.
2.3. Circular dichroism spectroscopy
His-tagged bCyP40 fragments were dialysed in 50 mM potassium
phosphate, pH 7.4 and diluted to 0.033 mg/ml protein in the same buf-
fer for analysis. Far UV CD measurements were performed in a Jascon constructs. The light shaded box depicts the PPIase domain and the
nker region. Numbers indicate CyP40 amino acid positions. The caret
is not to scale.
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were measured from 250 to 190 nm in a 1 cm path length quartz cuv-
ette and recorded as an average over 50 accumulations. Secondary
structure was assessed using the CDSSTR program available from
the DICHROWEB website [24,25].
2.4. Chaperone assays
An aggregation assay, using rhodanese as the substrate, was adapted
from published methods [8,26] and has been previously described [20].
The GST- and His-bCyP40 fusion, and GST control proteins were
analysed at concentrations of 0, 5, 10 and in some cases, 20 lM, in
chaperone assay buﬀer with denatured substrate (0.5 lM) and the rate
of rhodanese aggregation monitored over 20 min. Each protein was
checked for self-aggregation over a 5-min period.3. Results
3.1. CyP40 chaperone activity lies in the C-terminal half of the
protein and does not require an intact PPIase domain
Bovine CyP40 is characterized by a two-domain structure in
which the N-terminal catalytic domain is separated from the
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Fig. 2. Broad mapping of chaperone function in bovine CyP40. Denatured
presence of 5 lM (s), 10 lM (n) or 20 lM (h) GST control or GST-CyP40
absorbance normalised against runs with rhodanese alone and plotted as
aggregation is shown for: (A) GST-bCyP40 wild-type; (B) GST-bCyP40 1–1linker [19,27]. The chaperone function of the human CyP40
homologue has previously been demonstrated with the GST-
tagged recombinant protein [11,12]. To map the location of
the CyP40 chaperone domain we assessed the chaperone func-
tion of several GST fusion proteins incorporating bCyP40
deletion fragments (Fig. 1) using an aggregation assay with
rhodanese [26,28,29]. The extent of rhodanese aggregation in
the presence of GST-bCyP40 proteins is shown in Figs. 2
and 3.
Rhodanese aggregation was suppressible by GST-bCyP40
1–370 wild-type protein in a concentration-dependent manner
(Fig. 2A). At 20:1 chaperone:substrate molar ratio, the full-
length protein reduced rhodanese aggregation by approxi-
mately 45%. In control experiments, inhibition of rhodanese
aggregation was not evident at any concentration of GST pro-
tein tested (Fig. 2D). We observed no chaperone activity for
the 1–185 construct, corresponding to the isolated PPIase do-
main (Fig. 2B). However, the C-terminal 185–370 fragment,
incorporating the linker and TPR domain, retained chaperone
function. This deletion mutant decreased the level of rhoda-
nese aggregation by approximately 42% at 10 lM concentra-0 5 10 15 20
Time (min)










































rhodanese was diluted in assay buﬀer to 0.5 lM in the absence (d) or
fusion protein. Rhodanese aggregation was monitored at 320 nm and
percent aggregation over a 20-min period. The eﬀect on rhodanese
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Fig. 3. Fine mapping of chaperone function in bovine CyP40. Experimental conditions are as in Fig. 2. Rhodanese aggregation was monitored in the
absence (d) or presence of 5 lM (s) or 10 lM (n) GST-CyP40 fusion protein. The eﬀect on rhodanese aggregation is shown for: (A) GST-bCyP40
1–352, (B) GST-bCyP40 185–370D243–256, (C) GST-bCyP40 216-370 and (D) GST-bCyP40 1–213.
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length CyP40.
3.2. Distinct elements in CyP40 determine chaperone function
and Hsp90 interaction
Since our evidence suggested CyP40 chaperone function re-
sides within the C-terminal half of the protein, we next inves-
tigated whether the TPR domain, which is essential for
CyP40–Hsp90 interaction, plays a role in this activity. As part
of our experimental approach we assessed the chaperone func-
tion of deletion mutants that abrogated immunophilin binding
to Hsp90, allowing us to determine whether there was an over-
lap between these two functional domains within CyP40 or
whether they were distinct. The ﬁnal helix of the CyP40 struc-
ture (helix V, corresponding to residues 341–370) extends the
TPR domain [27] and contains the so-called charge-Y motif
[30] that contributes signiﬁcantly to CyP40–Hsp90 interaction
[20]. Deletion of 18-residues from the C-terminus of CyP40 in
the 1–352 construct, sharply reduced binding to Hsp90 com-
pared to full-length protein [19]. Intriguingly, the 1–352 frag-
ment showed an increased chaperoning ability over wild-type
CyP40, with an 80% reduction of rhodanese aggregation at20-fold excess of chaperone protein (Fig. 3A). It is possible
that this deletion relieved steric constraints to favor more eﬃ-
cient chaperone function. One cannot rule out, however, that
these changes may have exposed other features in the CyP40
protein resulting in increased chaperone potency.
To further evaluate the TPR domain for chaperone func-
tion, we created the 185–370D243–256 construct in which most
of helix Q in the ﬁrst TPR unit [27] has been eliminated. With
such a gross disruption of TPR domain structural integrity,
this deletion mutant was not able to bind Hsp90 (Fig. 4), but
the protein still displayed a chaperone function similar to the
185–370 construct (Fig. 3B, Fig. 2C). Although the ﬁrst TPR
unit in CyP40, based on the canonical 34-residue motif, begins
at Ser223, structural data shows that the ﬁrst helix (helix P) of
the TPR domain is longer, beginning with Val216 [27]. We
therefore prepared the 216–370 fragment that lacks the linker
region, but retains an intact TPR domain. This protein dis-
played a markedly reduced level of Hsp90 binding in compar-
ison to that seen with GST-CyP40 1–370 (Fig. 4), consistent
with our previous ﬁnding that the CyP40 linker may contribute
to Hsp90 interaction [19]. Fig. 3C shows that the 216–370 frag-
ment did not prevent rhodanese aggregation at 10-fold molar
Fig. 4. Binding of CyP40 deletion mutants to Hsp90. Puriﬁed GST-
bCyP40 1–370 wild-type or mutant fusion proteins were incubated
with puriﬁed His-hHsp90b 527–724 and then bound to glutathione-
Sepharose beads. For the ‘‘wash control’’, the Hsp90 fragment was
incubated with glutathione-Sepharose beads alone. After washing,
proteins retained on the beads were resolved on duplicate 12.5% SDS–
polyacrylamide gels and either visualized by Coomassie staining (top
panel) or subjected to Western blot with AC88 to detect Hsp90 bound
to CyP40 constructs (bottom panel).
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domain fragment was prone to self-aggregation.
Our data suggested that neither the PPIase nor the TPR do-
main mediate CyP40 chaperone activity. We therefore consid-
ered that the linker separating the two domains might fulﬁll
this role. Indeed, analysis of the 1–213 construct, containing
an intact cyclophilin domain and almost the entire linker re-
gion (Fig. 1), conﬁrmed chaperone activity for the protein,
although to a diminished extent compared to wild-type
CyP40 (Fig. 3D). Only a 34% reduction in rhodanese aggrega-
tion was observed at 20:1 molar ratio of chaperone to sub-
strate. Although the linker may also contribute to eﬃcient
CyP40–Hsp90 interaction, the key residues for Hsp90 binding
are located within the core TPR domain [22]. Taken together,
these results map the chaperone domain in CyP40 to the linker
region between amino acid residues 185–215 and conﬁrm dis-
tinct locations for the chaperone and Hsp90 binding functions
of the immunophilin.
Further veriﬁcation that the linker region mediates chaper-
one function was provided using His-tagged fusion proteins
for bCyP40 1–184, 1–215 and 1–235 (Fig. 5A), the latter frag-
ment containing the ﬁrst helix of the TPR domain [27]. Sec-
ondary structure was determined for these proteins by CD
spectroscopy. All three fragments displayed minima indicative
of a-helix and b-structure and these results are summarised in
Table 1. As a comparison, the secondary structure content for
these fragments, based on the available crystal data for
bCyP40 [31], is also shown. Overall, the secondary structure
of the His-tagged puriﬁed fragments of bCyP40 correlates well
with its crystal structure.
Analysis of the His-bCyP40 deletion mutants for chaperone
function revealed a lack of activity for the 1–184 fragment
(Fig. 5A), consistent with our earlier ﬁnding for GST-bCyP40
1–185 (Fig. 2B). The His-bCyP40 1–215 and 1–235 fragmentshowever, displayed chaperone properties, with observed reduc-
tions in rhodanese aggregation of 30% and 25%, respectively,
at 10 lM concentration (Fig. 5B and C). These ﬁndings were
comparable to that seen for the related construct, GST-
bCyP40 1–213 (Fig. 3D).
3.3. A hydrophobic cavity within the linker of CyP40 may
mediate chaperone function
Having delineated CyP40 chaperone function to the linker
between the PPIase and TPR domains, we examined the
intervening sequence for structural features that might favour
substrate interaction. In the intact CyP40 protein, the 30-res-
idue linker is structured through well-deﬁned hydrogen bonds
and contains 11 aspartate and glutamate residues with con-
necting salt bridges between residues Asp200 and Asp204
and helix Q of the TPR domain [27]. Ten hydrophobic resi-
dues are interspersed throughout the linker, six being located
between 200 and 215 (Fig. 6A). A further ﬁve hydrophobic
amino acids exist at the start of helix P from residues 216
to 222. In comparison to its yeast homologues, Cpr6 and
Cpr7, human CyP40 displays similar chaperone activity to
Cpr7, but is a more potent chaperone than Cpr6 [12,16].
Alignment of the linker sequences for bovine and human
CyP40 with those of Cpr6 and Cpr7, showed some conserva-
tion among acidic and hydrophobic residues (Fig. 6A). Close
examination of the CyP40 structure within the linker region
showed that the side chains of the hydrophobic amino acids
Phe205, Pro206, Val211 and Leu213 contribute to a hydro-
phobic surface within a cleft that is bounded on one side
by the PPIase domain and on the other by the ﬁrst unit of
the TPR domain (Fig. 6B). Side chains from the hydrophobic
residues Ile219 and Ile222, in helix P of the TPR domain and
the amphipathic Tyr252, located within helix Q, all project
into this cleft (Fig. 6B). The hydrophobic surface may serve
as a potential protein–protein interaction site to protect pep-
tide substrates from aggregation.4. Discussion
Using speciﬁcally designed bovine CyP40-derived deletion
mutants, coupled with a rhodanese aggregation assay, we
have located the chaperone domain of this immunophilin to
the 30-residue linker separating the PPIase and TPR do-
mains. Examination of CyP40 structure has revealed a hydro-
phobic cleft, within this linker region, that might be central to
the ability of the chaperone to accommodate and stabilize un-
folded or partially folded substrates. Our initial studies
showed retention of wild-type chaperone activity by the C-
terminal half of the protein (185–370), thus excluding a role
for PPIase activity in CyP40 chaperone function. The result
is consistent with an earlier ﬁnding, in which cyclosporin A
did not aﬀect the ability of CyP40 to maintain b-galactosi-
dase in an intermediary folded state [11] and that cyclophilin
domains generally, lack chaperone activity [32]. Chaperone
functions independent of PPIase activity have also been re-
ported for other prolyl isomerases, including FKBP52
[13,33] and trigger factor [34].
The C-terminal half of CyP40, which is comprised of the
linker region and TPR domain and determines CyP40 inter-
action with Hsp90, was further dissected for chaperone func-
Fig. 5. The CyP40 linker mediates chaperone function. (A) Schematic of His-bCyP40 fusion proteins for 1–184, 1–215 and 1–235. The shading
pattern is identical to that described in Fig. 1. The His tag is not to scale. These proteins were tested for chaperone function using experimental
conditions as in Fig. 2. Rhodanese aggregation was monitored in the absence (d) or presence of 5 lM (s) or 10 lM (n) GST-CyP40 fusion protein.
The eﬀect on rhodanese aggregation is shown for: (B) His-bCyP40 1–184; (C) His-bCyP40 1–215; and (D) His-bCyP40 1–235.
Table 1
Structural properties of His-bCyP40 fragments
bCyP40 Fragment a-Helix b-Structure NRMSD
CD-derived (%) Structure-derived (%) CD-derived (%) Structure-derived (%)
1–184 14 11 37 28 0.035
1–215 12 9 33 24 0.049
1–235 16 17 30 22 0.068
Far-UV CD data were recorded and analysed using the CDSSTR program found on the DICHROWEB website (http://www.cryst.bbk.ac.uk/cdweb/
html/). The NRMSD values were determined by ﬁtting the spectral data using proteins from Reference set 4. Actual secondary structure content was
calculated from the X-ray structure of bCyP40 [34].
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domain, was able to bind Hsp90, it was devoid of chaperone
activity. On the other hand, CyP40 185–370D243–256, which
contains a disrupted TPR domain thus precluding Hsp90
interaction, displayed wild-type chaperone activity. Retention
of chaperone function by GST-bCyP40 1–213 and His-
bCyP40 1–215 proteins, allowed us to conclude that the chap-
erone domain resides within the linker residues 185–215. Fur-
thermore, there was a clear separation of the CyP40 domains
that mediate chaperone activity and Hsp90 recognition. For
FKBP52, the chaperone domain has been localized to a re-
gion encompassing the TPR domain [33]. There is evidence
however, that intrinsic chaperone function and Hsp90 inter-action through the TPR domain occur at diﬀerent sites in
FKBP52 [33]. Similarly, an unstructured C-terminal region
in the Hsp90 cochaperone, p23, has been shown to be essen-
tial for its chaperone function, but is not involved in Hsp90
binding [14,15,35].
Within the CyP40 linker region we have identiﬁed a hydro-
phobic surface formed by amino acid residues Phe205,
Pro206, Val211 and Leu213, and the TPR helical residues
Ile219, Ile222 and Tyr252, that may provide a substrate-bind-
ing cavity for CyP40 chaperone function. The strand incorpo-
rating residues 200–212 may close up against the TPR helices,
forming the essential arm of a hydrophobic clamp around
potential peptide substrates, with TPR residues stabilizing
Fig. 6. The chaperone domain of CyP40 resides in a hydrophobic cavity within the linker region. (A) Sequence alignment of amino acids within the
linker (line above sequence) and part of the ﬁrst helix of the TPR domain of bovine CyP40 and its human and two yeast homologues, Cpr6 and Cpr7.
Acidic residues conserved with bCyP40 are indicated in bold. Conserved hydrophobic residues are boxed in grey. Residues identical among all four
immunophilins are boxed in black. (B) Solvent surface representation of bCyP40 highlighting a putative client protein binding cleft as shown within
the box. A magniﬁed view of the linker region is shown below the solvent surface representation highlighting hydrophobic residues proposed to be
involved in folding interactions with client proteins.
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phobic patch, located within or close to the TPR domain,
has been proposed to mediate interactions of non-native sub-
strate proteins with FKBP52 [33]. Speciﬁc aspartate and glu-
tamate residues within the CyP40 linker may help stabilize
the structure of the hydrophobic cavity and may also inﬂu-
ence substrate association. Selected acidic and hydrophobic
residues are partially conserved between the linker sequences
for human and bovine CyP40 and the yeast homologues,
Cpr6 and Cpr7, which display weak and potent chaperone
activity, respectively [16].
Within mature unactivated steroid receptor complexes, the
cooperative actions of multiple chaperone proteins hold the
receptor in a partially misfolded, and thus transcriptionally
repressed, conformation in readiness for activating hormonal
signal [4,5]. Dynamic receptor assembly and competing inﬂu-ences of the immunophilins with respect to Hsp90 binding,
together with immunophilin selectivity for speciﬁc receptors,
allows receptors to form distinct receptor-Hsp90-immunophi-
lin complexes, with receptor function being determined by the
immunophilin within the complex [4,5]. There is now accu-
mulating evidence for the direct interaction of immunophilins
with steroid receptors [5,10]. Additionally, there is growing
recognition that the interaction between Hsp90 and the
immunophilins is not limited to the C-terminal MEEVD rec-
ognition motif for TPR immunophilins, but may also involve
elements within the Hsp90 dimerization domain [36]. It is
possible therefore, for the target(s) of TPR immunophilin
chaperone function within steroid receptor complexes to be
either receptor and/or Hsp90. Either of these interactions
may help achieve an optimal conformation for receptor acti-
vation.
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